Life Science Fair Flemingsberg – Precision Health
Program (updated continuously, schedule coming soon):
Panel discussion – Health Economics
Precision medicine enables the delivery of the most appropriate treatment at the right time, based on individual factors such as a patient’s genetic profile, environment, and lifestyle. New advanced therapies are, in some cases, making it possible to cure conditions that were previously untreatable.However, these treatments may involve high upfront costs. Small patient populations in clinical trials, together with uncertainty around long-term effectiveness, make cost–benefit assessments more complex than for traditional pharmaceuticals. Welcome to this panel discussion exploring the health economic and broader socioeconomic considerations of implementing precision medicine.
Panelists: Peter Lindgren, Managing Director at IHE – The Swedish Institute for Health Economics, Professor of Health Economics at Karolinska Institutet, Marcelina Kadziela, Health Economist at The National Board of Health and Welfare (Socialstyrelsen), Fredrik Andersson, Chief Economist at Lif – The Swedish Association of the Pharmaceutical Industry, Anna Alaassad, Chief Strategist at TLV – The Dental and Pharmaceutical Benefits Agency.
Moderators: Andreas Namslauer, Process Manager & Filippa Kull, COO, Stockholm Science City Foundation.
PMCK – Implementing Precision Medicine in Routine Clinical Care
Andreas Hörnell, Chief of Staff, Precision Medicine Center Karolinska (PMCK)
About: Precision Medicine Center Karolinska (PMCK) is a virtual center dedicated to making precision medicine a part of everyday healthcare. Our mission is to remove barriers and facilitate drive change to bring cutting-edge technologies to every patient, leveraging the unique collaboration between Karolinska University Hospital and Karolinska Institutet.
Inhaled drug development
Ulf Wedenberg, Chief Commercial Officer, Inhalation Sciences
About: Pre-clinical studies are where the value of an asset is first established. To move the right candidate forward, researchers need reliable and predictive data that minimize clinical risk. Traditional models often fail to accurately predict human outcomes. Inhalation Sciences addresses this challenge by delivering data that better reflects how a drug will perform in humans.
ExtempoPrint – 3D-printing of compounded medicines
Christina Holmberg, Development Specialist, APL.
About: APL has introduced the ExtempoPrint concept for compounded medicines. 3D printing technology is particularly well suited for pharmacy preparations medicines, as it allows for high dosing accuracy and precision in the formulation. The technology also provides excellent opportunities for individualized dose adjustments. based on the patient’s needs.
Richard Rosenquist Brandell, Professor and senior physician in Clinical Genetics, Karolinska Institutet/Karolinska University Hospital, director Genomic Medicine Sweden
About: This talk will outline how genomic technologies has transformed clinical diagnostics and enabled precision medicine in areas such as rare diseases, cancer, and infectious diseases. It will describe the establishment of Genomic Medicine Sweden, including its regional Genomic Medicine Centres and the National Genomics Platform that will support secure data sharing across Sweden. Finally, the lecture will highlight key milestones, lessons learned, and future priorities for ensuring sustainable and equitable access to genomics-based precision medicine in healthcare.
High multiplexing in ddPCR – closing the gap to NGS in precision medicine
Pelle Larshammar, Regional ddPCR Specialist, EMEA
About: Droplet digital PCR (ddPCR) has, over the past decade, become and established method in the clinical laboratory. Its ability to detect and quantify rare, patient specific DNA targets, such as cancer-associated mutations, has supported clinicians in selecting the right treatment for the right patient. In this seminar, we will highlight how ddPCR can also be applied in a screening-like approach, offering higher sensitivity, lower cost, and shorter time-to-result compared with NGS.
Implementing Precision Medicine through SciLifeLab
Rikard Göran Fred, Research Infrastructure Specialist, SciLifeLab
About: The SciLifeLab infrastructure provides cutting-edge technologies to enable excellent research in life science. Through the Clinical Genomics platform, SciLifeLab has already played a major role in implementing precision medicine in Sweden and is now working to improve the accessibility for both academia and industry.
Mimer – Sweden’s AI Factory: Free Computing Power for SMEs and More
Petra Dalunde, Head of AI Ecosystem and Policy Mimer, Coordinator Formal Test & Evaluation AI, Coordinator – CitCom.ai, Rise
About: The European Commission is invention €200 billion in AI to strengthen Europe’s independence and capabilities in the field. As part of this initiative, 19 AI Factories are being established to provide free computing capacity to innovative European SMEs across all domains. Petra Dalunde will introduce Mimer, Sweden’s AI Factory, and explain who can receive support, what support is available, and how to apply and join the program.
Exhibitions throughout the day from:
ThermoFisher, Nordic Biosite, CCRM Nordic, QVance, BioNordika, METTLER TOLEDO, Atlas Antibodies, ACROBiosystems & Apotek Produktion & Laboratorier (APL).
Practical details:
Lunch and refreshments are served for all registered participants.
